Prodeon Medical

Prodeon Medical is a clinical-stage medical device company pivoting its focus to urology with its investigational Urocross Expander System for treating Lower Urinary Tract Symptoms (LUTS) due to BPH. The technology aims to offer a minimally invasive, potentially anesthesia-light alternative to medications and traditional surgeries like TURP, targeting a large and growing patient population dissatisfied with current options. The company is currently conducting a clinical study for the PURE procedure and appears to be in a pre-revenue, late-stage development phase as a private entity.

Urocross Expander System for minimally invasive Prostatic Urethral Reshaping (PURE) procedure.

Prodeon competes in the crowded BPH space against pharmaceutical giants (e.g., makers of alpha-blockers, 5-ARIs) and established medical device companies with approved MISTs like Teleflex's UroLift, Boston Scientific's Rezūm, and various laser ablation systems. Differentiation will require demonstrating comparable efficacy with a better side-effect or recovery profile.